IDO1 and neoplasm: The MFIs of FITC-labelled anti-IDO antibodies in the primary and distant tumor tissues and TDLNs of SPNpro-injected and photoirradiated mice were greatly decreased by 10.9, 12.3, and 3.4 times relative to that of the saline-injected mice, respectively.